Trial intelligence / Profile preview

Tranexamic Acid in Anemic Patients Undergoing OPCAB

NCT01067638Phase 4Completed

Sponsor
Yonsei University
Start
Nov 2009
Primary completion
Sep 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial of tranexamic acid in postoperative hemorrhage, sponsored by Yonsei University. Primary endpoints: Amount of Homologous Transfusion at 24 hours and Incidence of Homologous Transfusion at 24 hours. Started Nov 2009; status: completed.

02

Drugs

tranexamic acid
03

Conditions

postoperative hemorrhage

Beyond the preview

Go deeper on NCT01067638.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01067638.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call